GMDA News and Press, Gamida Cell Ltd. From 11/04/21

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for cancer and other serious diseases, today announced that Aviad Pato, Ph.D., Head of Immunology Research, presented data on two nicotinamide (NAM)-enabled NK cell therapies, GDA-501 and GDA-301, a...

Today, we revisit an intriguing Israeli-based biotech concern called Gamida Cell for the first time since March. The shares have seen declines in 2021, like most small biotechs this year, even as the company continues to march to its first FDA approval. Time to buy the dip? A full...

Company recently filed an IND application for GDA-201; FDA placed the application on Clinical Hold pending modifications to donor eligibility procedures and sterility assay qualification Today’s presentations to highlight expanded NAM-enabled NK cell therapy platf...

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for cancer and other serious diseases, today announced that data evaluating the company’s NAM-enabled NK cell platform will be presented at the Society for Immunotherapy of Cancer’s 36...

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that it will host a virtual event detailing the company’s proprietary NAM-enabled natural killer (NK) cell therapy pipeline on Tuesda...

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that company management will present its corporate highlights at the following virtual investor conferences in September: H.C. Wainwri...

Image source: The Motley Fool. Gamida Cell Ltd. (NASDAQ: GMDA) Q2 2021 Earnings Call Aug 11, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Gamida Cell Ltd. (GMDA) Q2 2021 Earnings Call Transcript

Gamida Cell Ltd (GMDA) Q2 2021 Earnings Conference Call August 11, 2021, 08:00 ET Company Participants Joshua Hamermesh - Chief Business Officer Julian Adams - CEO & Director Ronit Simantov - Chief Medical Officer Michele Korfin - Chief Operating & Chief Commercial Officer Shai Lankry...

The following slide deck was published by Gamida Cell Ltd. in conjunction with their 2021 Q2 earnings call. For further details see: Gamida Cell Ltd. 2021 Q2 - Results - Earnings Call Presentation

BLA submission for omidubicel, a potentially life-saving treatment for patients with blood cancers in need of stem cell transplant, expected in fourth quarter of 2021 Commercial readiness activities underway to support potential launch in 2022 Phase 1/2 clini...